12/12
08:17 am
krbp
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01 [Yahoo! Finance]
Medium
Report
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01 [Yahoo! Finance]
12/12
08:00 am
krbp
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Medium
Report
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
12/3
11:08 am
krbp
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation [Yahoo! Finance]
Neutral
Report
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation [Yahoo! Finance]
12/3
11:02 am
krbp
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation
Neutral
Report
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation
10/8
08:00 am
krbp
Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01
Medium
Report
Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01
10/1
08:00 am
krbp
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial
Medium
Report
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial